ASE Details M-TEER Imaging Guidance - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

ASE Details M-TEER Imaging Guidance

The guideline emphasizes standardized image orientation and heart team communication during mitral valve transcatheter edge-to-edge repair.

  • By

  • mdspire news news staff

  • June 22, 2026

  • 9 min

Share

Clinical Report: ASE Details M-TEER Imaging Guidance

Overview

The American Society of Echocardiography has published new guidelines to standardize intraprocedural imaging for mitral valve transcatheter edge-to-edge repair (M-TEER). These guidelines address variability in imaging protocols.

Background

Mitral valve transcatheter edge-to-edge repair (M-TEER) is increasingly performed across various centers, necessitating standardized imaging protocols to ensure consistent procedural outcomes. Variability in imaging can impact procedural success and patient outcomes.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

  • The guideline emphasizes the importance of transesophageal echocardiographic (TEE) guidance in M-TEER procedures.
  • A stepwise imaging protocol is outlined, covering nine procedural stages from baseline evaluation to final deployment.
  • Baseline transmitral gradient and mitral valve area (MVA) thresholds are specified to minimize risks associated with mitral stenosis.
  • Minimum posterior leaflet length requirements are defined for different devices used in M-TEER.
  • Transseptal puncture is highlighted as a critical procedural step, with specific recommendations for puncture site positioning.

Clinical Implications

Understanding the specific imaging requirements and thresholds outlined in the guidelines can assist in the assessment and planning of M-TEER procedures.

Conclusion

The ASE's guidelines for intraprocedural imaging in M-TEER provide recommendations to enhance procedural success and patient safety.

Related Resources & Content

  1. American Society of Echocardiography, Journal of the American Society of Echocardiography, 2026 -- Guidelines for the Intraprocedural Imaging for Mitral Valve Transcatheter Edge-to-Edge Repair (M-TEER)
  2. CLASP IID Trial and Registry: 2-Year Outcomes of Transcatheter Repair for Degenerative Mitral Regurgitation | JACC: Cardiovascular Interventions
  3. Implementation of a Stereotactic Frame-Assisted Drill Guide for Laser Interstitial Thermal Therapy
  4. Augmented Reality CT-US Fusion with Smart Goggles Versus Traditional Navigation Techniques for Percutaneous Needle Placement
  5. Preliminary Phantom Investigations of a Low-Field MRI System for Prostate Biopsy in an Office Setting
  6. European Radiology — Advantages of MRI-Guided Freehand Biopsy for Small Focal Liver Lesions Compared to CT-Guided Approaches
  7. Guidelines for the Intraprocedural Imaging for Mitral Valve Transcatheter Edge-to-Edge Repair (M-TEER): Recommendations from the American Society of Echocardiography
  8. CLASP IID Trial and Registry: 2-Year Outcomes of Transcatheter Repair for Degenerative Mitral Regurgitation | JACC: Cardiovascular Interventions
  9. Mitral Transcatheter Edge-to-Edge Repair Versus Guideline-Directed Medical Therapy for Functional Mitral Regurgitation With Heart Failure: An Updated Meta-analysis - PubMed

Original Source(s)

ASE Details M-TEER Imaging Guidance

  • by mdspire news news staff

  • June 22, 2026

Related Content

Case report: Additional Imaging Supports TAPVR Care

A case report shows that advanced cardiac CT and MRI imaging can improve surgical planning and reintervention for patients with infradiaphragmatic total anomalous pulmonary venous return (TAPVR). See what Sebastián Quiñones-Carrasquillo, MD, and co-authors Todd Nowlen, MD and Daniel Velez, MD, recommend for using these advanced diagnostic imaging modalities.

  • by

  • August 12, 2026

  • 6 min
Medical Oddities: The ghost that haunted a heart

From haunted hearts to toxic treats, medicine has a few Halloween tricks up its sleeve.

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.